Laurent Pharmaceuticals' Unattributed Round

Laurent Pharmaceuticals raised a round of funding on September 19, 2018.

Laurent Pharmaceuticals is a Canada-based clinical stage company focusing on rare inflammatory diseases. Laurent's lead drug candidate, LAU-7b, is a Phase 2 ready oral drug addressing the compromised …

Articles about Laurent Pharmaceuticals' Unattributed Round: